MRPs may drop by 70%
Department of Pharmaceuticals is moving to cap trade margins at 30% on high-priced cancer drugs, potentially slashing retail MRPs by 70%.
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →